Shionogi announces positive top-line efficacy results from year-long studies of velneperit, a novel NPY Y5 receptor antagonist being investigated for the treatment of obesity.
In: Chemical Business Newsbase, 2009-02-17
Zeitungsartikel
Zugriff:
Titel: |
Shionogi announces positive top-line efficacy results from year-long studies of velneperit, a novel NPY Y5 receptor antagonist being investigated for the treatment of obesity.
|
---|---|
Zeitschrift: | Chemical Business Newsbase, 2009-02-17 |
Veröffentlichung: | 2009 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|